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Background: Aortic injury is the second most common cause of death after blunt trauma. Thoracic endovascular aortic
repair (TEVAR) has been rapidly adopted as an alternative to the traditional open repair (OR) for treatment of traumatic
aortic injury (TAI). This paradigm shift has improved the outcomes in these patients. This study evaluated the outcomes
of TEVAR compared with OR for patients with TAI.
Methods: We analyzed prospectively collected data from the institutional trauma registry between April 2002 and June
2010. These data were supplemented with a retrospective review of hospital financial accounts. The primary outcome was
the presence or absence of any complication, including in-hospital death. Secondary outcomes included fixed, variable,
and total hospital costs and intensive care unit (ICU), preoperative, postoperative and total hospital length of stay (LOS).
Results:Amongst 106 consecutive patients (74 men; mean age, 36.4 years), 56 underwent OR and 50 underwent TEVAR
for treatment of TAI. The proportion of patients who underwent TEVAR compared with OR increased from 0% to 100%
during the study period. The TEVAR patients were significantly older than the OR patients (41.1 vs 32.2 years, P 
.012). For patients who underwent TEVAR, the estimated odds ratio (95% confidence interval) of complications,
including in-hospital mortality was 0.33 (0.11-0.97; P  .045) compared with the OR group. The average number of
complications, including in-hospital death, was higher in the OR group than in the TEVAR group (adjusted means, 1.29
vs 0.94). The OR group had a higher proportion of patients with complications, including in-hospital death, compared
with the TEVAR group (69.6% vs 48%). Although, the mean adjusted variable costs were higher for TEVAR than for OR
(P .017), the mean adjusted fixed and total costs were not significantly different. Owing to a policy of delayed selective
management, the adjusted preoperative LOS was significantly higher for TEVAR (9.8 vs 3.0 days, P  .022). The
difference in the ICU or total hospital LOS was not significant. Although the proportion of uninsured patients was
similar in both groups, the cohort (n  106) had a significantly higher proportion of uninsured patients (29% vs 5%)
compared with the general vascular surgical population at our institution (0.29 vs 0.051, 95% confidence interval for
difference in proportions, 0.22-0.40; P < .0001).
Conclusions: Compared with TEVAR, patients who underwent OR had three times higher odds to face a complication or
in-hospital death. The mean total cost of TEVAR was not significantly different than OR. The findings support the use
of TEVAR over OR for patients with TAI. (J Vasc Surg 2013;57:108-15.)
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dTraumatic aortic injury (TAI) is the second most com-
mon cause of death after blunt trauma.1,2 The mechanism
is likely related to a complex combination of relative mo-
tion of the structures within the thorax and local loading of
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108he tissues because of the anatomy or the nature of the
mpact.3 In the aorta, the greatest strain occurs at the
sthmus.4 A 1958 article by Parmley reported an 85%
rehospital mortality rate in patients with TAI.5 Tradi-
ional open repair (OR) has been associated with high
orbidity and mortality.6 Thoracic endovascular aortic
epair (TEVAR) has been rapidly adopted for treatment of
AI. Several meta-analysis have documented significantly
mproved outcomes with TEVAR compared with OR.7-9
ore recently, the Society for Vascular Surgery Clinical
ractice Guidelines suggested, “that endovascular repair be
erformed preferentially over open surgical repair or non-
perativemanagement.”10 The purpose of this study was to
valuate the outcomes of TEVAR compared with OR for
atients with TAI who were treated at a major urban
rauma center.
ETHODS
This study was approved by the Committee for the
rotection of Human Subjects, which acts as the institu-
ional review board. We analyzed prospectively collected
ata from the institutional trauma registry between April
002 and June 2010. These data were supplemented with a
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Volume 57, Number 1 Azizzadeh et al 109retrospective review of hospital financial accounts. The
fixed, variable, and total costs for each patient’s index
hospital stay were extracted from the institution’s account-
ing records.
Patients suspected of having TAI were screened with
computed tomography (CT) angiography (CTA) on ar-
rival. We classified TAIs into four categories by severity (Fig
1)11: grade 1, intimal tear; grade 2, intramural hematoma;
grade 3, aortic pseudoaneurysm; and grade 4, free rupture.
Initial management included resuscitation, blood pressure
control, and treatment of associated injuries. Patients with
grade 1 injuries underwent intravascular ultrasound
(IVUS) imaging and were managed medically, those with
grade 2 or grade 3 injuries were considered for elective
repair after treatment of associated injuries, and patients
with grade 4 injuries underwent immediate repair on ar-
rival.
Before September 2005 all patients underwent OR
using distal aortic perfusion. Our technique for OR of TAI
has been described previously.12 In summary, all proce-
dures were performed under general anesthesia using a
double-lumen endotracheal tube. Distal aortic perfusion
using a Bio-Medicus (Minneapolis, Minn) pump with an
in-line heat exchanger was used with outflow cannulation
from the left inferior pulmonary vein to the distal descend-
ing thoracic aorta or left common femoral artery. Systemic
heparinization was used at 1 mg/kg.
Aortic clamping was performed proximal to the left
Fig 1. Classificationsubclavian artery. The aorta was opened longitudinally, and ehe tear was inspected. Hemostasis was obtained by over-
ewing any bleeding intercostal arteries. An appropriately
ized woven Dacron tube graft was anastomosed to the
roximal aorta with a running 4-0 polypropylene suture.
he distal anastomosis was performed, and the graft was
ushed just before it was completed. The heparin was
eversed using protamine. Postoperatively, patients re-
urned to the trauma surgical intensive care unit (ICU).
Endovascular repair with the off-label use of a U.S.
ood and Drug Administration– approved thoracic device
as initiated in September 2005. The suitability of a patient
or endovascular repair was determined by the aortic diam-
umatic aortic injury.
able I. Baseline comparison of patients in the open
epair (OR) and thoracic endovascular aortic repair
TEVAR) groups
ariable
OR TEVAR
P(n  56) (n  50)
ale, No. (%) 39 (69.6) 35 (70.0) .99
ge, mean (SD) years 32.16 (14.23) 41.06 (20.32) .01a
SS, mean (SD) 37.96 (9.98) 36.68 (9.81) .51
CS, mean (SD) 11.11 (5.28) 10.94 (5.19) .87
PS, mean (SD) 0.76 (0.30) 0.73 (0.29) .57
AI, mean (SD) grade 2.71 (0.49) 2.72 (0.36) .95
CS, Glasgow Coma Scale; ISS, Injury Severity Score; RPS, Revised Prob-
bility of Survival; TAI, traumatic aortic injury.
Statistically significant.ter according to the manufacturer’s sizing recommenda-
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Patients who were not endovascular candidates underwent
OR.
Our technique for TEVAR of TAI has been described
previously.11 In summary, all TEVARs were performed in a
hybrid operating room equipped with fixed imaging equip-
ment (Axiom; Seimens Medical, Malvern, Pa). The patient
was placed under general anesthesia and the abdomen and
bilateral groins were prepared in standard fashion. An arch
aortogram was performed through percutaneous femoral
access. The location of the injury was confirmed. The arch
angiogram was used to evaluate the cerebrovascular anat-
omy, especially if left subclavian artery coverage was
planned. IVUS imaging was used selectively on the discre-
tion of the attending surgeon. The patient was anticoagu-
lated with a weight-based heparin protocol.
The thoracic device(s) (off-label) were selected based
on CT images according to the manufacturer’s sizing rec-
ommendations. Measurements were made based on two-
dimensional thin-cut axial CT scans with intravenous con-
trast. The device (or devices) was delivered and deployed
using standard technique without any pharmacologic ad-
junct.
The subclavian artery was covered as needed to obtain a
proximal landing zone or gain better apposition with the
lesser curvature of the aortic arch. A policy of selective
delayed subclavian artery revascularization was maintained.
Postdeployment balloon angioplasty was performed selec-
tively when incomplete apposition of the graft at the prox-
imal landing zone was noted.
Heparin was reversed using protamine. Patients re-
turned to the trauma surgical ICU after their operation and
were discharged after treatment of other associated injuries.
The primary outcome was the presence or absence of
any complication, including in-hospital death. Complica-
tions included cardiac, respiratory, gastrointestinal, neuro-
logic, hematologic, peripheral vascular, infectious, renal,
and other. Neurologic complications were further subdi-
Table II. Comparison of the primary outcomea
Variable Unadjusted
Group, TEVAR vs OR 0.40 (0.18-0.89)
Age, years 1.02 (0.99-1.04)
Sex, female vs male 1.46 (0.61-3.46)
Injury Severity Score 1.02 (0.98-1.07)
Glasgow Coma Scale 0.93 (0.85-1.01)
Revised Probability of Survival 0.075 (0.013-0.445)
Traumatic aortic injury 1.13 (0.53-2.42)
CI, Confidence interval; OR, open repair; TEVAR, thoracic endovascular a
aPresence of complications, including in-hospital death (univariable and mu
(female vs male), Injury Severity Score, Glasgow Coma Score, Revised Prob
were cardiac, respiratory, gastrointestinal, stroke, paraplegia, other neurolog
bStatistically significant.vided into stroke, paraplegia, other neurologic, and all leurologic. All complications captured in our institutional
rauma registry were reported.
Secondary outcomes included fixed, variable, and total
ospital costs, and also ICU, preoperative, postoperative,
nd total hospital length of stay (LOS). Technical success
or OR was defined as the ability to successfully repair the
AI. Technical success for TEVAR was defined as the
bility to successfully exclude the TAI without a type I
ndoleak. Follow-up surveillance imaging for the TEVAR
roup consisted of a CTA at 1, 6, and 12 months, and
early thereafter. Follow-up data were gathered from clin-
cal records. This was supplemented with a review of the
ocial Security Death Index on each patient.
The sample size was based on all available patients with
AI who underwent TEVAR or OR at our institution
etween April 2002 and June 2010. From a review of the
s ratio (95% CI) for TEVAR vs OR
P
Adjusted
P
ivariable) (multivariable)
.025b 0.33 (0.11-0.97) .045b
.20 0.99 (0.95-1.03) .54
.39 1.74 (0.56-5.38) .34
.27 0.92 (0.85-0.99) .019b
.077 1.49 (1.09-2.03) .011b
.0014b .001 (0.001-0.009) .00067b
.75 1.90 (0.69-5.27) .22
epair.
ble analysis). Results were adjusted (logistic regression) for age (years), sex
of Survival, and traumatic aortic injury grades 1-4. Complications included
neurologic, hematologic, peripheral vascular, infectious, renal, and other.
able III. Descriptive results: proportion of individual
omplications and in-hospital death by study group
ariablea
OR TEVAR
(n  56) (n  50)
No. (%) No. (%)
omplication  death 39 (69.64) 24 (48.00)
omplication  death, mean 1.29 0.94
eath 5 (8.9) 2 (4.0)
ardiac 5 (8.93) 3 (6.00)
espiratory 32 (57.14) 18 (36.00)
astrointestinal 4 (7.14) 2 (4.00)
troke 2 (3.57) 1 (2.00)
araplegia 0 0
ther neurologic 4 (7.14) 1 (2.00)
ll neurologic 6 (10.71) 2 (4)
ematologic 7 (12.7) 5 (10.00)
eripheral vascular 2 (3.57) 0
nfectious 6 (10.71) 6 (12.00)
enal 10 (17.86) 4 (8.00)
ther 6 (10.71) 5 (10.00)
R, Open repair; TEVAR, thoracic endovascular aortic repair.
Data are shown as number (%) except where indicated.Odd
(un
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35% for TEVAR.6,8 Assuming that TEVAR could poten-
tially reduce complications, including in-hospital mortality
by 50% compared with open repair (relative risk, 0.5), we
calculated that a sample size of 50 in each group would be
sufficient to detect a significant difference with a power of
95% (two-sided   .05).
In the baseline comparisons, t test and 2 tests were
applied to continuous and categoric variables, respectively.
When the assumptions of the 2 test were not met in the
expected cell size, the Fisher exact test was applied to
binary variables. For the primary outcome, the logistic
regression model was used to compare the two groups
(OR vs TEVAR) while controlling for potential confound-
ing by other covariates, including age, sex (female vs male),
Injury Severity Score (ISS), Glasgow Coma Scale (GCS),
Revised Probability of Survival (RPS), and TAI grades
(1-4). For the secondary outcomes, linear regression was
used to compare the two groups (OR vs TEVAR) while
controlling for potential confounding by other covariates,
including age, sex (female vs male), ISS, GCS, RPS, and
TAI grade (1-4). To adjust for potential confounding
caused by year of surgery, a subgroup analysis using logistic
regression was performed on patients who underwent re-
pair between 2005 and 2009. This period was selected
due to the overlap of OR and TEVAR. Because we had
only one primary outcome, we tested our primary hy-
pothesis at the 5% level of significance. All other compari-
sons, including the secondary outcome were conducted at
the 5% level of significance and were not adjusted for
multiple comparisons. Statistical analyses were performed
using SAS 9.2 software (SAS Institute, Cary, NC).
RESULTS
A total of 106 consecutive patients (74 men; mean, age
36.4 years) underwent OR (n 56) and TEVAR (n 50)
for treatment of TAI. Detailed data are reported in Tables
I-IV. The mechanism of injury is demonstrated in Fig 2.
Table IV. Comparison of secondary outcome variables be
Variable
OR
(n  56)
Cost
Variable 54,940 (37,587, 72,292)
Fixed 21,433 (15,511, 27,354)
Total 104,313 (77,634, 130,993)
Length of stay
ICU 19.80 (14.69, 24.92)
Pre-op 2.77 (0, 6.35)
Post-op 30.12 (24.14, 36.11)
Total 32.89 (25.81, 39.98)
CL, Confidence limits; ICU, intensive care unit; OR, open repair; TEVAR,
aResults were adjusted (linear regression) for age (years), sex (female vs male)
traumatic aortic injury grades (1-4).
bStatistically significant.The proportion of patients who underwent TEVAR com- Aared with OR increased from 0% to 100% during the study
eriod (Fig 3). At the baseline comparison, the TEVAR
atients were significantly older than the OR patients (41.1
s 32.2 years, P  .012). The groups did not differ signif-
cantly in baseline ISS, GCS, RPS, or TAI grade.
The primary outcome is reported in Table II. The odds
atio of any complication, including in-hospital death for
EVAR compared with OR was 0.33 (95% confidence
nterval [CI], 0.11-0.97; P .045). There was a reduction
n themean number of complications, including in-hospital
eath per patient in the TEVAR group compared to OR
0.94 vs 1.29). The OR group had a higher proportion of
atients with complications, including in-hospital death,
ompared with the TEVAR group (69.6% vs 48%).
The univariable and multivariable analysis of the results
f the secondary outcomes are reported in Table IV. The
djusted mean variable costs were higher for TEVAR com-
ared with OR (P  .017). The adjusted mean fixed costs
ere not significantly different between the groups, nor
ere the adjusted mean total costs. The differences in total
OS and ICU LOS were not significant; but the preoper-
tive and postoperative LOS was significantly different be-
ween the two groups. This was primarily due to a policy of
elayed selective management. The preoperative LOS was
ignificantly higher for TEVAR (adjusted mean, 9.8 vs 3.0
ays; P  .022) resulting in a significantly shorter postop-
rative LOS (adjusted mean, 15.7 vs 28.7 days; P .0021)
ompared with the OR group.
There were no operative deaths. One OR procedure
as stopped because the patient was not able to tolerate
ingle-lung ventilation. This patient subsequently under-
ent TEVAR without any complications. The technical
uccess rates were 98.2% for OR and 100% for TEVAR.
verall, 52 devices were implanted: 33 TAG (W. L. Gore
nd Associates, Flagstaff, Ariz) and 18 Talent (Medtronic,
anta Rosa, Calif). All but two patients received a single
evice. One pediatric patient underwent repair of her TAI
ith the iliac limb of an Excluder device (W. L. Gore and
n groups by univariable and multivariable analysisa
onadjusted, mean (95% CL)
TEVAR
(n  50) P
85,757 (67,393, 104,121) .017b
25,498 (19,232, 31,764) .35
115,890 (91,232, 140,548) .53
16.94 (11.53, 22.35) .45
11.14 (7.35, 14.93) .0019b
16.88 (10.54, 23.22) .0033b
28.02 (20.52, 35.52) .35
cic endovascular aortic repair
y Severity Score, Glasgow Coma Score, Revised Probability of Survival, andtwee
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(36%) of the TEVAR patients. Delayed left subclavian
revascularization was performed in two patients during the
follow-up period. Reflex sympathetic dystrophy developed
in the left arm in a patient with an associated brachial plexus
injury. He underwent a left carotid-subclavian bypass on
postoperative day 75. The second patient, a 72-year-old
man, presented 5 years postoperatively with syncope. An
angiogram revealed evidence of left vertebral artery athero-
sclerosis. He underwent a left carotid subclavian bypass on
postoperative day 1821. The patient has not had any syn-
copal episodes since the procedure. No other secondary
interventions were required.
To investigate the potential year effect, we performed a
subgroup analysis with the data from years with both
treatment groups (ie, years 2005-2009). The estimated
odds ratio of TEVAR vs OR for complications from logistic
regression models with and without the year effect is 0.63
and 0.66 (univaraiable andmultivariable), respectively. The
change in odds ratios was5%, and we concluded that the
year did not have any confounding effect in our final
findings.
Although the proportions of uninsured patients were
similar in both groups, the TAI cohort as a whole (n 106)
had a significantly higher proportion of uninsured patients
(29% vs 5%) compared with the general vascular surgical
population at our institution (0.29 vs 0.051, 95%CI for the
difference in proportions, 0.22-0.40; P  .0001). The
median follow-up time for the cohort was 1604 days and
was significantly higher for OR group than for TEVAR
(median, 2257 vs 506 days; P .0046). This difference was
partly due to the late adoption of TEVAR in the study
period. Only 32% of the TEVAR patients were fully com-
pliant with their follow-up surveillance imaging protocol. A
Kaplan-Meier curve demonstrates the distribution of sur-
vival in the cohort over time (Fig 4). Seven patients in each
group died during the follow-up period, resulting in a
survival proportion of 87.5% in the OR group and 86% in
the TEVAR group; however, this difference was not statis-
Table IV. Continued.
Adjusted, m
OR
(n  56)
51,356 (33,114, 69,598) 8
18,913 (13,646, 24,180) 2
96,944 (70,892, 122,996) 10
17.43 (13.03,21.84)
3.00 (0, 7.28)
28.73 (22.74, 34.73)
31.74 (24.87, 38.60)tically significant (P  .43). pFinally, during the study period, five patients with
rade 1 injuries weremanagedmedically using anti-impulse
herapy. This consisted of short-acting intravenous
-blocker administration to maintain a systolic blood pres-
ure of 120 mm Hg and a heart rate 90 beats/min.
atients were weaned to oral therapy when possible. A
ollow-up CT scan at 6 weeks confirmed healing in all
atients.
ISCUSSION
This study represents a large contemporary series of
rauma patients treated at amajor urban level 1 trauma center.
he results of the primary outcome of complications, includ-
ng in-hospital death, weigh in favor of TEVAR over OR.
ur logistic regression analysis showed that compared
ith TEVAR, patients who underwent OR had more
han more than three times more odds of having com-
lications, including in-hospital death. The findings in
his study support the preferential use of TEVAR for
atients with TAI. Consistent findings have been re-
orted in the literature.7-9,14-16 It is important to note
hat the overall injury pattern has a significant effect in the
Fig 2. Mechanisms of injury.
(95% CL)
TEVAR
(n  50) P
0 (64,390, 99,209) .017b
8 (18,701, 28,754) .18
7 (86,326, 129,668) .52
8 (11.38, 19.79) .54
2 (5.74, 13.91) .022b
4 (10.03, 21.46) .0021b
7 (19.01, 32.12) .19ean
1,80
3,72
7,99
15.5
9.8
15.7
25.5rimary outcomes, death, and complications and that OR
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Volume 57, Number 1 Azizzadeh et al 113vs TEVAR repair is only one component of the global
treatment plan.
Our cost analysis showed a higher adjusted mean vari-
able costs for TEVAR than for OR (P .017). The variable
cost includes supplies or devices used, operating room
time, LOS staff time (nursing), pharmacy, and imaging use.
A likely partial explanation for this difference is the cost of
the devices implanted. The adjusted mean fixed costs were
not significantly different. Fixed costs refer to the overhead
expenses that do not depend on the number of patients
treated. The study, however, showed no significant differ-
ence in the adjusted mean total costs between the OR and
Fig 3. Treatment of traumatic aortic injury: the proporti
(TEVAR) increased from 0% to 100% from April 2, 200
Fig 4. A Kaplan-Meier curve demonstrates the distribu
TEVAR, thoracic endovascular aortic repair.TEVAR groups. tThe literature reporting hospital costs reflects mixed
ndings. We are aware of three studies that have compared
he cost of OR vs TEVAR. Two studies were from Canada
nd reported conflicting results. The study from Alberta
eported comparable procedure costs but higher follow-up
ost for TEVAR (USD$59,170 for OR vsUSD $61,266
SD $428 per year for TEVAR).14 The study from On-
ario reported decreased total 1-year costs for TEVAR
ompared with OR (USD $70,442 vs USD $72,833).15
he only published study in the United States analyzed the
005-2006Nationwide Inpatient Sample and found signif-
cantly higher hospital costs for OR.16 To our knowledge,
patients undergoing thoracic endovascular aortic repair
une 2, 2010. OR, Open repair.
of survival in the cohort over time. OR, Open repair;on oftionhe current study represents the only single-institution analysis
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United States. The findings do not reflect a significant differ-
ence in total hospital costs between OR and TEVAR. This
supports continued use of TEVAR as the treatment of choice
for patient with TAI.
The study observed a significantly higher proportion of
uninsured patients in the TAI cohort than in the general
vascular surgery population at our institution. This has
major implications for follow-up. The current evidence
supports TEVAR over OR for treatment of patients with
TAI. However, TEVAR includes additional follow-up
surveillance imaging, and the precise protocol for this
follow-up imaging regimen in TAI patients has not been
defined. The Society for Vascular Surgery Practice Guide-
lines acknowledge that this process “remains in evolution.”
Although some panel members suggested decreasing the
frequency of follow-up imaging in stable patients to every 2
to 5 years, others argued that, lacking any evidence to the
contrary, follow-up for TAI patients should be no different
from those undergoing TEVAR for other pathologies.10 In
our cohort, only 32% of the TEVAR patients were fully
compliant with their follow-up imaging. Without a doubt,
lack of funding plays a major role. Although some limited
funding is provided to trauma centers in Texas, currently,
the only mechanism for obtaining elective follow-up care in
uninsured patients is the county health care system.
The limitations of the study include the retrospective
nature of the analysis and the limited sample size. In addi-
tion, owing to the recent adoption of TEVAR, the
follow-up period in this cohort is shorter than in the OR
group. We were also unable to adjust for the cost of
inflation during the study period. Other potential con-
founding variables that were not available include race,
socioeconomic status, and baseline health status.
CONCLUSIONS
Compared with TEVAR, patients who underwent OR
had three times higher odds to face a complication or
in-hospital death. The mean total cost of TEVAR was not
significantly different compared with OR. The findings
support the use of TEVAR over OR for patients with TAI.
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fDISCUSSION
Dr Robert J. Feezor (Gainesville, Fla). I congratulate the
authors on an impressive series comparing open and endovascular
management of traumatic aortic transection in which there was a
statistically significant reduction in the rate of complications with
endovascular therapy. I have several questions for the authors. You
listed in tabular format that the predominant complication in both
groups was respiratory. Is this truly a complication of the aortic
treatment or a complication of the causative injury?
Second, in the Methods section, you mention that grade 1
injuries by computed tomography (CT) scan were further evaluated
with intravascular ultrasound (IVUS) imaging and then medically
managed if truly grade 1. What was the correlation between CT and
IVUS imaging? How many patients fell into this category, and was
there any clinical or radiographic follow-up for these patients?
Third, you waited an average of 11 days from injury to
endovascular repair. This brings to light a larger debate as to which
transected aortas need to be repaired at all. Do you have any data
supporting repair of aortic transections that are stable enough to
survive 11 days? As a corollary question, were there any patients in
this series who were being stabilized but then were urgently taken
for open repair (OR) or endovascular therapy because of some
change in clinical appearance?
Again, I enjoyed your manuscript and presentation, and am
grateful for the opportunity to lead the discussion.
Dr Ali Azizzadeh. Thank you very much, Bob. With regard
to respiratory complications, many are related to the initial trauma. Towever, as shown in the study, patients who underwent open
epair had a higher risk of developing pneumonia, respiratory
ailure, ventilator dependence, and other respiratory complica-
ions. With regard to management of grade 1 injuries, we recently
ublished our experience with the use of IVUS in the Journal of
ascular Surgery. In patients with suspected aortic injury who had
n equivocal CT scan, IVUS was more sensitive than aortogram as
follow-up imaging study. With regard to the follow-up imaging
f patients with grade 1 aortic injuries, we have had five patients
hat healed on follow-up CT scan performed 6 weeks after the
njury. The patients with grade 1 injuries are medically treated with
nti-impulse control.
With regard to the interval to repair, we follow these patients
ery closely; however, if they have an associated head or abdominal
njury that requires emergent treatment, we allow for the other
pecialists to intervene before treating the aortic injury, as long as
he patient remains hemodynamically stable. If the patients are
nstable, they are taken to the operating room emergently for
horacic endovascular aortic repair (TEVAR) or open repair as
ndicated. During the study period, since April of 2002, we have
ot lost any patients to aortic rupture after admission. There have
een patients who have died on arrival. We have practiced delayed
elective management as advocated by other centers, but moving
orward, we are starting to be more aggressive with doing early
EVAR in the first 24 to 48 hours. Thank you.
